Article Editorial Article Document Information Content Entity Continuant Continuant Entity Entity Generically Dependent Continuant 2025-06-24T09:31:50 RDF description of Romosozumab versus Alendronate and fracture risk in women with osteoporosis [editorial] - http://repository.healthpartners.com/individual/document-rn2558 378 public Romosozumab versus Alendronate and fracture risk in women with osteoporosis [editorial] New England Journal of Medicine Fractures Risk Factors 2 document-rn2558 10.1056/NEJMc1714810 26090 Osteoporosis editorial 2022-02-21T22:48:57.408-06:00 15755 Drugs and Drug Therapy